COVID-19

Showing NaN - NaN of 49

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

COVID-19, SARS-CoV-2 Trial in Puerto Rico, United States (Abatacept, Placebo)

Terminated
  • COVID-19
  • SARS-CoV-2
  • Abatacept
  • Placebo
  • Hialeah, Florida
  • +9 more
Jul 6, 2022

COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

Completed
  • COVID-19
  • Birmingham, Alabama
  • +71 more
Jun 22, 2022

Subsequent and Co-infections Associated With SARS-CoV-2

Completed
  • COVID-19
  • Observational
  • Dallas, Texas
    Methodist Dallas Medical Center
May 24, 2022

COVID-19 Breakthrough Infection in Fully Vaccinated People and

Enrolling by invitation
  • COVID-19 Pneumonia
  • COVID-19
  • Pfizer COVID-19 mRNA vaccine
  • Moderna COVID-19 mRNA vaccine
  • Dallas, Texas
    Methodist Dallas Medical Center
May 24, 2022

COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)

Completed
  • COVID
  • +3 more
  • Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
  • +2 more
  • Colorado Springs, Colorado
  • +38 more
Mar 31, 2022

COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

Completed
  • COVID-19
  • Interferon beta-1a
  • +2 more
  • Birmingham, Alabama
  • +63 more
Mar 9, 2022

COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

Completed
  • COVID-19
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +70 more
Mar 9, 2022

COVID-19 Trial in United States (Remdesivir (RDV), Placebo)

Completed
  • COVID-19
  • Remdesivir (RDV)
  • Placebo
  • Mesa, Arizona
  • +27 more
Feb 18, 2022

COVID-19 Vaccine Response in Sickle Cell Disease

Recruiting
  • Sickle Cell Disease
  • COVID-19
  • COVID-19 Vaccine
  • Washington, District of Columbia
  • +5 more
Dec 2, 2021

COVID-19 Trial in Dallas (Experimental Group, Placebo Group)

Completed
  • COVID-19
  • Experimental Group
  • Placebo Group
  • Dallas, Texas
    University of Texas Medical Center
Dec 12, 2021

COVID-19 Trial in United States (Gimsilumab, Placebo)

Completed
  • COVID-19
  • Phoenix, Arizona
  • +32 more
Dec 10, 2021

COVID-19 Trial in Worldwide (RDV, Placebo to Match RDV)

Terminated
  • COVID-19
  • RDV
  • Placebo to Match RDV
  • Chandler, Arizona
  • +103 more
Nov 4, 2021

COVID-19, SARS-CoV 2 Trial in United States (Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine)

Terminated
  • COVID-19
  • SARS-CoV 2
  • Hydroxychloroquine (HCQ)
  • +3 more
  • Birmingham, Alabama
  • +10 more
Nov 12, 2021

Methodist Health System COVID-19 Patient Registry

Recruiting
  • COVID-19
  • Treatment for COVID-19
  • Dallas, Texas
    Clinical Research Institute Methodist Health System
Nov 9, 2021

Cardiovascular Manifestations of COVID-19

Recruiting
  • COVID-19
  • Chart review
  • Dallas, Texas
    Methodist Dallas Medical Center
Nov 9, 2021

Corona Virus Infection, Covid19, COVID-19 Trial in Worldwide (Awake Proning)

Completed
  • Corona Virus Infection
  • +2 more
  • Awake Proning
  • Dallas, Texas
  • +16 more
Oct 14, 2021

COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)

Completed
  • COVID-19
  • Aurora, Colorado
  • +33 more
Oct 8, 2021

COVID-19 Trial in United States (Sarilumab, Placebo)

Completed
  • COVID-19
  • Los Angeles, California
  • +61 more
Sep 16, 2021

COVID-19 Trial in Dallas (Hydroxychloroquine)

Completed
  • COVID-19
  • Dallas, Texas
    Baylor University Medical Center
Aug 18, 2021

Predictors of Severe COVID-19 Outcomes

Active, not recruiting
  • Acute Respiratory Distress Syndrome
  • COVID-19
    • Tucson, Arizona
    • +7 more
    Aug 16, 2021

    COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)

    Completed
    • COVID-19
    • Anaheim, California
    • +183 more
    Jan 21, 2021

    COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)

    Completed
    • COVID-19
    • Anaheim, California
    • +182 more
    Dec 15, 2020